Correlation Between Fate Therapeutics and Atara Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Atara Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Atara Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Atara Biotherapeutics, you can compare the effects of market volatilities on Fate Therapeutics and Atara Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Atara Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Atara Biotherapeutics.
Diversification Opportunities for Fate Therapeutics and Atara Biotherapeutics
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Fate and Atara is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Atara Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atara Biotherapeutics and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Atara Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atara Biotherapeutics has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Atara Biotherapeutics go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Atara Biotherapeutics
Given the investment horizon of 90 days Fate Therapeutics is expected to generate 2.02 times less return on investment than Atara Biotherapeutics. But when comparing it to its historical volatility, Fate Therapeutics is 1.41 times less risky than Atara Biotherapeutics. It trades about 0.01 of its potential returns per unit of risk. Atara Biotherapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,527 in Atara Biotherapeutics on August 24, 2024 and sell it today you would lose (466.00) from holding Atara Biotherapeutics or give up 30.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fate Therapeutics vs. Atara Biotherapeutics
Performance |
| Timeline |
| Fate Therapeutics |
| Atara Biotherapeutics |
Fate Therapeutics and Atara Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fate Therapeutics and Atara Biotherapeutics
The main advantage of trading using opposite Fate Therapeutics and Atara Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Atara Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atara Biotherapeutics will offset losses from the drop in Atara Biotherapeutics' long position.| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
| Atara Biotherapeutics vs. Lyra Therapeutics | Atara Biotherapeutics vs. Hookipa Pharma | Atara Biotherapeutics vs. Cingulate Warrants | Atara Biotherapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |